Affymetrix Strikes Agreements With Roche Molecular, Eos Biotech | GenomeWeb

SANTA CLARA, Calif.--GeneChip developer Affymetrix here and Roche Molecular Systems announced a joint effort to develop and market a new generation of diagnostic tests that combines Affymetrix's GeneChip DNA probe array technology with Roche's PCR gene amplification technology. The companies will initially develop diagnostic kits for applications in HIV drug resistance. The agreement provides a framework for the development of additional GeneChip diagnostic kits as the parties identify further product opportunities.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.